Literature DB >> 11703368

Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice.

S Farkas1, H Herfarth, M Rössle, J Schroeder, M Steinbauer, M Guba, A Beham, J Schölmerich, K W Jauch, M Anthuber.   

Abstract

Leucocyte recruitment to sites of intestinal inflammation is a crucial, multi-step process that leads ultimately to the accumulation of cells in the inflamed tissue. We established a new in vivo model system of experimental colitis to quantify leucocyte-endothelial cell interaction and leucocyte extravasation in the inflamed mucosa of the colon. Furthermore, we investigated the pathophysiological role of ICAM-1 in the intestinal microcirculation in vivo. Using the model of dextran sodium sulphate (DSS)-induced acute and chronic colitis in mice, in vivo microscopy was performed in the colonic submucosal postcapillary venules and the submucosal collecting venules in normal or inflamed murine colonic segments. ICAM-1 expression was blocked by an anti-ICAM-1 monoclonal antibody or by suppressing NF-kappaB activation by gliotoxin. Significant increases in leucocyte adhesiveness (51-fold in postcapillary venules, 30-fold in collecting venules, P < 0.01) and extravasation (6.5-fold) could be demonstrated as early as day 2 of DSS-application in acute colitis (P < 0.01). This was paralleled by increases in both the histological damage scores and myeloperoxidase activities. In chronic dextran sodium sulphate-induced colitis significant increases in leucocyte-endothelium interactions and leucocyte extravasation were observed. Blocking ICAM-1 expression with a monoclonal antibody or gliotoxin, leucocyte sticking and extravasation were significantly down-regulated in vivo compared to controls (> 70%; P < 0.01). This new model system offers the possibility to specifically assess the role of adhesion molecules in the colonic mucosa in vivo as well as to investigate and quantify the effectiveness of experimental therapeutic approaches in acute or chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703368      PMCID: PMC1906186          DOI: 10.1046/j.1365-2249.2001.01544.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  An improved intravital microscopy system.

Authors:  A G Harris; R Hecht; F Peer; D Nolte; K Messmer
Journal:  Int J Microcirc Clin Exp       Date:  1997 Nov-Dec

Review 2.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.

Authors:  M Göke; J C Hoffmann; J Evers; H Krüger; M P Manns
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

4.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

5.  An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice.

Authors:  C F Bennett; D Kornbrust; S Henry; K Stecker; R Howard; S Cooper; S Dutson; W Hall; H I Jacoby
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

6.  Adhesion molecules in inflammatory bowel disease.

Authors:  S C Jones; R E Banks; A Haidar; A J Gearing; I K Hemingway; S H Ibbotson; M F Dixon; A T Axon
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

7.  Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats.

Authors:  T Taniguchi; H Tsukada; H Nakamura; M Kodama; K Fukuda; T Saito; M Miyasaka; Y Seino
Journal:  J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 4.029

8.  Colonic antioxidant status in dextran sulfate-induced colitis in mice.

Authors:  A C Blackburn; W F Doe; G D Buffinton
Journal:  Inflamm Bowel Dis       Date:  1997       Impact factor: 5.325

9.  Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice.

Authors:  Y Arai; H Takanashi; H Kitagawa; I Okayasu
Journal:  Cytokine       Date:  1998-11       Impact factor: 3.861

10.  Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors.

Authors:  C Jobin; C Hellerbrand; L L Licato; D A Brenner; R B Sartor
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more
  11 in total

1.  Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies.

Authors:  Yoshiaki Hayashi; Kenta Narumi; Shigetsugu Tsuji; Toshinari Tsubokawa; Masa-aki Nakaya; Tomohiko Wakayama; Masahiko Zuka; Tohru Ohshima; Masakazu Yamagishi; Toshihide Okada
Journal:  Int J Colorectal Dis       Date:  2011-06-15       Impact factor: 2.571

2.  Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats.

Authors:  Ping Zheng; Feng-Li Niu; Wen-Zhong Liu; Yao Shi; Lun-Gen Lu
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

3.  Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis.

Authors:  G Paul; F Bataille; F Obermeier; J Bock; F Klebl; U Strauch; D Lochbaum; P Rümmele; S Farkas; J Schölmerich; M Fleck; G Rogler; H Herfarth
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Fundamental and distinct roles of P-selectin and LFA-1 in ischemia/reperfusion-induced leukocyte-endothelium interactions in the mouse colon.

Authors:  Amjid Ali Riaz; Ming Xiu Wan; Thilo Schaefer; Rene Schramm; Henrik Ekberg; Michael D Menger; Bengt Jeppsson; Henrik Thorlacius
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

5.  Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.

Authors:  Tomo-O Ishikawa; Masanobu Oshima; Harvey R Herschman
Journal:  Carcinogenesis       Date:  2010-12-14       Impact factor: 4.944

6.  Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis.

Authors:  Stefan Farkas; Matthias Hornung; Christine Sattler; Karoline Edtinger; Markus Steinbauer; Matthias Anthuber; Hans J Schlitt; Hans Herfarth; Edward K Geissler
Journal:  Int J Colorectal Dis       Date:  2005-04-23       Impact factor: 2.571

7.  Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.

Authors:  Stefan Farkas; Matthias Hornung; Christine Sattler; Markus Guba; Markus Steinbauer; Matthias Anthuber; Hans Herfarth; Hans J Schlitt; Edward K Geissler
Journal:  Int J Colorectal Dis       Date:  2005-10-14       Impact factor: 2.571

8.  Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  S Farkas; M Hornung; C Sattler; M Anthuber; U Gunthert; H Herfarth; H J Schlitt; E K Geissler; B M Wittig
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

9.  Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis.

Authors:  Thorsten Vowinkel; Theodore J Kalogeris; Mikiji Mori; Christian F Krieglstein; D Neil Granger
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

10.  Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.

Authors:  P Stopfer; F Obermeier; N Dunger; W Falk; S Farkas; M Janotta; A Möller; D N Männel; T Hehlgans
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.